Reducing your risk for melanoma by 20 percent could be as easy as popping aspirin, at least if you’re a woman over age 50. A new study in the journal Cancer looked at melanoma in 60,000 post-menopausal Caucasian women. Over a 12-year period, women who took aspirin twice a week or more had a 20 percent lower risk of developing melanoma, the most progressive form of skin cancer.
The results applied to aspirin use only and not other non-steroidal anti-inflammatory drugs, such as ibuprofen.
Before aspirin can be prescribed to patients at risk for melanoma, clinical trial testing must be performed. Additionally, pain relievers increase a user’s risk of bleeding and pose other potentially serious side effects. The only proven method of skin cancer prevention is avoiding UV exposure and using sun protection (a wide brim hat, sunscreen and sun protective clothing).
Currently, researchers plan to do follow-up studies in younger women and men.
As always, talk with your doctor regarding your health concerns.
Disclaimer: The information provided by Coolibar and its contributors is general skin care information and should not be a substitute for obtaining medical advice from your physician and is not intended to diagnose or treat any specific medical problem.
Resources: CBS News; FOX News; NPR
Photo credit: Wikipedia
